期刊文献+

局限期小细胞肺癌三维适形超分割放疗及同步化疗的临床研究 被引量:1

Clinical outcomes of concurrent accelerated fractionation plus three-dimension conformal radiotherapy and chemotherapy for limited-stage small cell lung cancer
下载PDF
导出
摘要 目的:观察三维适形超分割放疗及同步化疗治疗局限期小细胞肺癌(LSCLC)的疗效及不良反应。方法:50例LSCLC患者随机分为同步化疗及三维适形超分割放疗DT54Gy组(治疗组)和三维适形超分割放疗DT45Gy组(对照组)。化疗采用EP方案化疗:足叶乙甙(VP-16)100mg/m2,第1-5天;顺铂(DDP)40mg/m2,第1-3天化疗一周期,再同步放化疗,然后继续化疗,共4-6周期。放疗采用三维适形超分割放疗,1.5Gy次/,2次/d,间隔≥6h,5d周/。治疗组肿瘤量DT54Gy,对照组DT45Gy。结果:治疗组与对照组的近期有效率(CR+PR)分别为92.0%和84.0%。1、2、3年生存率分别为80.0%、40.0%、24.0%和76.0%、32.0%、16.0%(P>0.05)。中位生存期分别为24.6和22.3个月。1+2级放射性食管炎、肺炎、骨髓抑制发生率相似。结论:3DCRT超分割放疗及同步化疗在总剂量为54Gy组可获得满意的近、远期疗效,不良反应稍高但可以耐受。 Objective: To evaluate the effect of EP regimen delivered concurrently with accelerated fractionation plus three-dimension conformal radiotherapy(3DCRT)for locally small cell lung cancer(LSCLC).Methods: Fifty patients with LSCLC were randomized into two groups: 25 patients received chemotherapy and accelerated fractionation plus three-dimension conformal radiotherapy DT 54Gy(treatment group),25 patients received chemotherapy and accelerated fractionation plus three-dimension conformal radiotherapy DT 45Gy(control group).Chemotherapy ragimen EP(VP-16+DDP).In both groups,patients received one cycle chemotherapy,followed by concurrent chemoradiotherapy and then received consolidate chemotherapy.Chemotherapy was used for four to six cycles of EP regimen.Radiotherapy ragimen accelerated fractionation plus three-dimension conformal radiotherapy.1.5Gy per fraction,twice daily.The total dose in treatment group and control group was 54Gy and 45Gy.Results: The overall response rate was 92.0% in treatment group,while 84.0% in control group;The 1,2 and 3 year survival rate in treatment group and control group were 80.0%,40.0%,24.0% and 76.0%,32.0%,16.0%(P0.05).The median survival time was 24.6 and 22.3 months.There was no difference in grade 1+2 acute radiation esophagitis,pneumonitis and myelo-suppression between the two groups.Conclusion: The accelerated fractionation plus three-dimension conformal radiotherapy(DT 54Gy) and chemotherapy can achieve satisfactory short-term and long-term outcomes in patients with LSCLS and tolerable to toxicities.
出处 《现代肿瘤医学》 CAS 2011年第6期1144-1146,共3页 Journal of Modern Oncology
关键词 小细胞肺癌 化学疗法 超分割放射治疗 三维适形放射治疗 small cell lung cancer chemotherapy accelerated fractionation radiotherapy three-dimension conformal radiotherapy
  • 相关文献

参考文献10

二级参考文献79

共引文献40

同被引文献14

  • 1Ginsberg MS. Epidemiology of lung cancer[J]. Semin Roentgenol, 2005,40 (2) : 83-89.
  • 2Janssen HL,Haustermans KM,Balm AJ,et al. Hypoxia in head and neck cancer: how much, how important? [J]. Head Neck, 2005,27(7) : 622-638.
  • 3Sohda M, Ishikawa H, Masuda N, et al. Pretreatrnent evaluation of combined HIF Jalpha,p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer[J]. Int J Cancer, 2004,110(6) : 838-844.
  • 4Greijer AE,van der Wall E. The role of hypoxia inducible factor1 (HIF-1) in hypoxia induced apoptosis[J].J Clin Pathol,2004, 57(10) :1009- 1014.
  • 5Lee MJ, Kim JY, Suk K, et al. Identification of the hypoxia-inducible factor 1 alpha-responsive HGTD-P gene as a mediator in the mito- chondrial apoptotic pathway[J]. Mol Cell Biol, 2004,24(9) : 3918- 3927.
  • 6Erler JT, Cawthorne CJ, Williams KJ, et al. Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia in- ducible factor 1-dependent and -independent mechanisms and contributes to drug resistance[J ]. Mol Cell Biol, 2004,24 ( 7 ) 2875-2889.
  • 7Moeller BJ,Dreher MR,Rabbani ZN,et al. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity[J]. Cancer Ce11,2005, 8(2) :99-110.
  • 8Goda N,Ryan HE,Khadivi B, et al. Hypoximinducible factor 1alpha is essential for cell cycle arrest during hypoxia[J]. Mol Cell Biol, 2003,23(1) :359-369.
  • 9Garcia-Barros M,Paris F Cordon-Cardo C, et ak Tumor response to radiotherapy regulated by endothelial cell apoptosis[J]. Science, 2003,300(5622) : 1155-1159.
  • 10Moeller BJ,Dewhirst MW. HIF-1 and tumour radiosensitivity[J]. Br J Cancer,2006,95(1) :1-5.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部